HIV / AIDS in the News

Commentary: Retaliation has no place in public health - Orlando Sentinel

 

A Look At Gilead Sciences (GILD) Valuation After FDA Priority Review For New HIV Tablet - simplywall.st

 

Massachusetts HIV Legislation Strategy - blog.outtakeonline.com

 

Microaneurysms in HIV-negative cytomegalovirus retinitis: an uncommon finding - Nature

 

Physical activity and hypertension amongst HIV-positive and HIV-negative populations in rural South Africa - Nature

 

Idvynso: New HIV Medication Approved by the FDA - TheBody

 

Trump admin plans to divert $2 billion in health funding to pay for USAID closure - CNN

 

Bangor moving forward with syringe pilot program amid ongoing HIV outbreak - WGME

 

HIV Rapid Test Kits Market to Reach USD 4.86 Billion by 2033 - openPR.com

 

Social media card: AIDS-related mortality - Nearing the target - European Centre for Disease Prevention and Control

 

‘Stronger together to end AIDS’ is the resounding call at the International Francophone Conference on HIV - UNAIDS

 

Can GPs Help End HIV Transmission by 2030? - Medscape

 

Manitoba declares public health emergency as HIV rates rise - CBC

 

GILD Q1 Deep Dive: HIV Growth, Oncology Pipeline, and Margin Management Shape 2026 Outlook - StockStory

 

HIV and COVID-19: What You Should Know - HIV.gov

 

National HIV Initiatives Data - Centers for Disease Control and Prevention | CDC (.gov)

 

9 lessons to make SA’s anti-HIV jab roll-out work - Bhekisisa

 

New study tracks HIV care after hospital discharge statewide - News-Medical

 

HIV-1 Remodels Nuclear Pores in Resting CD4+ T Cells to Facilitate Infection - geneonline.com

 

HIV-1 Alters Nuclear Pores to Enable Infection - Bioengineer.org

 

Trump health aid deals raise fears over HIV treatment - 23ABC News Bakersfield

 

[BHIVA/BASHH 2026] HIV i-Base: HIV and neurodiversity includes higher concerns over adherence - European AIDS Treatment Group

 

Science: A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys - European AIDS Treatment Group

 

New York University: Marker of biological aging linked to some but not all symptoms of depression - European AIDS Treatment Group

 

Infectious Disease Advisor: HIV increases mortality risk in patients with hepatocellular carcinoma - European AIDS Treatment Group

 

Queen Mary University of London: Scientists discover how HIV hijacks a cellular 'gateway' to infect resting immune cells - European AIDS Treatment Group

 

United and Unbreakable: The HIV Movement at 45 - poz.com

 

Infection Control Today: Aging with HIV: What the next major challenge is for drug development - European AIDS Treatment Group

 

HIV-1 Bypasses Resting Immune Cells Through Novel Gateway, Reveals Queen Mary University Study - geneonline.com

 

California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' - Reuters